PUBLISHER: MarketsandMarkets | PRODUCT CODE: 1681002
PUBLISHER: MarketsandMarkets | PRODUCT CODE: 1681002
The global Medical humidifier market is projected to reach USD 1,211.7 million by 2029 from USD 922.8 million in 2024, at a CAGR of 5.6% during the forecast period. This is due to increasing cases of COPD, asthma, sleep apnea, pneumonia, and bronchitis, growing air pollution, smoking, and climate change are worsening respiratory conditions, necessitating humidification therapy, newborns and infants, especially premature babies, require humidified oxygen therapy in neonatal intensive care units (NICUs), and aging populations and rising healthcare costs are driving a shift toward home-based treatments. But recurring costs for maintenance, replacement parts (filters, chambers), and energy consumption add to financial burden, and poor maintenance or improper cleaning can lead to bacterial and mold growth, increasing infection risks.
Scope of the Report | |
---|---|
Years Considered for the Study | 2022-2029 |
Base Year | 2023 |
Forecast Period | 2023-2029 |
Units Considered | Value (USD million) |
Segments | Product, Application, Distribution Channel, Patient type, End User, and Region |
Regions covered | North America, Europe, APAC, LATAM, MEA, GCC Countries |
"The heated humidifier segment of medical humidifier market by product to hold largest market share during forecast period."
Based on the product, the medical humidifier market is divided into Heated Humidifier, Bubble Humidifier , Heat and Moisture Exchangers (HMEs), and Humidifier Accessories. Among these, in 2023 heated humidifier segment account for the largest market share of in medical humidifier market. This is due to the increasing use of Heated humidifiers in mechanical ventilation, oxygen therapy, and non-invasive ventilation (NIV) to prevent airway dryness and irritation, rising geriatric population who are more prone to respiratory conditions, and regulatory support from the US Food and Drug Administration (FDA), Conformite Europeene (CE) (Europe), and other global bodies ensures product quality and drives market confidence.
"The intensive care unit (ICU) segment of medical humidifier market by application to hold largest market share during the forecast period."
Based on application, the medical humidifier market is segmented into Intensive Care Unit (ICU), Neonatal Care, Respiratory Therapy, and Other Applications. The intensive care unit (ICU) segment accounts for the largest market share in medical humidifier market due to increasing hospitalizations due to severe respiratory diseases, pneumonia, and post-surgical recovery, premature infants require respiratory support with humidified oxygen in neonatal intensive care units (NICUs), and public and private healthcare investments in ICU capacity expansion are increasing humidifier adoption. Moreover, The pandemic highlighted the need for advanced ICU humidification systems for ventilated patients.
"Asia Pacific to hold the highest CAGR of the medical humidifier market by region."
The global medical humidifier market is segmented into six major regions, namely, North America, Europe, Asia Pacific, Latin America, Middle East & Africa, and GCC Countries. Asia Pacific is estimated to grow at the highest CAGR during the forecast period. This is attributed to an aging population and chronic disease management at home. Japan, South Korea, and China's aging populations are more likely to develop respiratory problems and require ICU admissions. The governments of China, India, Japan, and Southeast Asia are investing in ICU growth to improve critical care. Low-birth-weight and premature babies often suffer with respiratory problems and need humidified oxygen therapy. The OECD estimates that the average neonatal mortality rate in lower-middle- and low-income APAC countries in 2022 will be 15.6 deaths per 1,000 live births. Japan, China, India, Australia, and the rest of Asia Pacific comprise the region. In the medical humidifier market in 2023 China boasts the highest market share. This is ascribed to China's aging population, rising awareness, investments in healthcare facilities, and rising frequency of respiratory diseases including COPD and asthma. With more than 280 million individuals aged 60 and above as of the end of 2022, or 19.8% of the whole population, China has the highest aging population worldwide.
Note 1: Note: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 1.0 billion, Tier 2 = USD 500.0 million to USD 1.0 billion, and Tier 3 = <USD 500.0 million.
Note 2: C-level primaries include CEOs, CFOs, COOs, and VPs.
Note 3: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
The major players operating in the medical humidifier market are include ResMed Inc. (US), Dragerwerk AG & Co. KGaA (Germany), Fisher & Paykel Healthcare Limited (New Zealand), Koninklijke Philips N.V. (Netherlands), Vincent Medical Holdings Limited (Hong Kong), Medline Industries, LP. (US), Hamilton Medical (Switzerland), GaleMed Corporation (Taiwan), and Eakin Healthcare (UK).
Research Coverage
This report studies the medical humidifier market based on product, application, distribution channel, patient type, end user and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to six major regions (and the respective countries in these regions).
Reasons to Buy the Report
The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.